As a knowledge-based company, Parand Darou pharmaceutical company started its activity in 2006 with the production of Narcotic APIs. Parand Darou Company is the second company in the private sector that received the license to produce narcotic products from the Food and Drug Organization of Iran. Extracting the Opioid raw materials, manufactured effective medicinal substances such as Codeine Phosphate, Noscapine, Thebaine, Papaverine and Oxycodone, in addition to meet the needs of domestic customers, it has exported its products to the world markets. In 2019, the company established a syrup line and received a GMP certificate and launched the production cycle of narcotic FDF as well. In July 2022, Kimyagaran Group (public stock) purchased the management shares of Parand Darou Pharmaceutical Company and aims to create a turning point in the growth, development and excellence of the company by cooperating with the expert and experienced management team.